tetrazepam
{{Short description|Chemical compound}}
{{cs1 config|name-list-style=vanc|display-authors=6}}
{{Drugbox
| verifiedrevid = 447572810
| IUPAC_name = 7-chloro-5-(cyclohexen-1-yl)-1-methyl-3H-1,4-benzodiazepin-2-one
| image = Tetrazepam.svg
| image_class = skin-invert-image
| width = 222
| image2 = Tetrazepam3d.png
| image_class2 = bg-transparent
| width2 = 200
| tradename =
| Drugs.com = {{drugs.com|international|tetrazepam}}
| pregnancy_category =
| legal_BR = B1
| legal_BR_comment = {{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=Diário Oficial da União |language=pt-BR |publication-date=2023-04-04}}
| legal_CA = Schedule IV
| legal_DE = Rx-only/Anlage III
| legal_UK = Class C
| legal_US = Schedule IV
| routes_of_administration = Oral
| bioavailability =
| metabolism =
| elimination_half-life = 3–26 hours
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 10379-14-3
| ATC_prefix = M03
| ATC_suffix = BX07
| PubChem = 25215
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 23551
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = FO92091VP8
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07277
| C=16 | H=17 | Cl=1 | N=2 | O=1
| smiles = CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CCCCC3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H17ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h5,7-9H,2-4,6,10H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = IQWYAQCHYZHJOS-UHFFFAOYSA-N
}}
TetrazepamNL Patent 6600095 (brand names Clinoxan, Epsipam, Myolastan, Musaril, Relaxam and Spasmorelax) is a benzodiazepine derivative with anticonvulsant, anxiolytic, muscle relaxant and slightly hypnotic properties. It was formerly used mainly in Austria, France, Belgium, Germany and Spain to treat muscle spasm, anxiety disorders such as panic attacks, or more rarely to treat depression, premenstrual syndrome or agoraphobia. Tetrazepam has relatively little sedative effect at low doses while still producing useful muscle relaxation and anxiety relief. The Co-ordination Group for Mutual Recognition and Decentralised Procedures-Human (CMD(h)) endorsed the Pharmacovigilance Risk Assessment Committee (PRAC) recommendation to suspend the marketing authorisations of tetrazepam-containing medicines across the European Union (EU) in April 2013.[http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Tetrazepam_containing_medicinal_products/human_referral_prac_000015.jsp&mid=WC0b01ac05805c516f Recommendation to suspend tetrazepam-containing medicines endorsed by CMDh], European Medicines Agency, published 29 April 2013 The European Commission has confirmed the suspension of the marketing authorisations for Tetrazepam in Europe because of cutaneous toxicity, effective from the 1 August 2013.[http://www.akdae.de/Arzneimittelsicherheit/RHB/Archiv/2013/20130624.pdf Ruhen der Zuhlassung aller Tetrazepam-haltiger Arzneimittel], Sanofi-Avensis Deutschland GmbH (German), published June 2013
Delayed type 4 allergic hypersensitivity reactions including maculopapular exanthema, erythematous rash, urticarial eruption, erythema multiforme, photodermatitis, eczema and Stevens–Johnson syndrome can occasionally occur as a result of tetrazepam exposure. These hypersensitivity reactions to tetrazepam share no cross-reactivity with other benzodiazepines.{{cite journal | vauthors = Thomas E, Bellón T, Barranco P, Padial A, Tapia B, Morel E, Alves-Ferreira J, Martín-Esteban M | title = Acute generalized exanthematous pustulosis due to tetrazepam | journal = Journal of Investigational Allergology & Clinical Immunology | volume = 18 | issue = 2 | pages = 119–22 | year = 2008 | pmid = 18447141 | url = http://www.jiaci.org/issues/vol18issue2/7.pdf }}
Indications
Tetrazepam is used therapeutically as a muscle relaxant.{{cite journal | vauthors = Simiand J, Keane PE, Biziere K, Soubrie P | title = Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants | journal = Archives Internationales de Pharmacodynamie et de Therapie | volume = 297 | pages = 272–85 | date = January 1989 | pmid = 2567153 }}{{cite journal | vauthors = Perez-Guerrero C, Herrera MD, Marhuenda E | title = Relaxant effect of tetrazepam on rat uterine smooth muscle: role of calcium movement | journal = The Journal of Pharmacy and Pharmacology | volume = 48 | issue = 11 | pages = 1169–73 | date = November 1996 | pmid = 8961167 | doi = 10.1111/j.2042-7158.1996.tb03915.x | s2cid = 38144317 }}
Availability
The indicated adult dose for muscle spasm is 25 mg to 150 mg per day, increased if necessary to a maximum of 300 mg per day, in divided doses. Tetrazepam is not generally recommended for use in children, except on the advice of a specialist.
Tetrazepam is only available in one strength and formulation, 50 mg tablets. The benzodiazepine equivalent of tetrazepam is approximately 100 mg of tetrazepam = 10 mg of diazepam.{{cite web| url=http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html| title=Benzodiazepine Names| access-date=2009-04-05| publisher=non-benzodiazepines.org.uk| url-status=dead| archive-url=https://web.archive.org/web/20081208054743/http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html| archive-date=2008-12-08}}
Adverse effects
Allergic reactions to tetrazepam occasionally occur involving the skin.
Allergic reactions can develop to tetrazepam{{cite journal | vauthors = Camarasa JG, Serra-Baldrich E | title = Tetrazepam allergy detected by patch test | journal = Contact Dermatitis | volume = 22 | issue = 4 | pages = 246 | date = April 1990 | pmid = 2140761 | doi = 10.1111/j.1600-0536.1990.tb01587.x | s2cid = 26973793 }}{{cite journal | vauthors = Collet E, Dalac S, Morvan C, Sgro C, Lambert D | title = Tetrazepam allergy once more detected by patch test | journal = Contact Dermatitis | volume = 26 | issue = 4 | pages = 281 | date = April 1992 | pmid = 1356710 | doi = 10.1111/j.1600-0536.1992.tb00259.x | s2cid = 43750783 }} and it is considered to be a potential allergen.{{cite journal | vauthors = Ortiz-Frutos FJ, Alonso J, Hergueta JP, Quintana I, Iglesias L | title = Tetrazepam: an allergen with several clinical expressions | journal = Contact Dermatitis | volume = 33 | issue = 1 | pages = 63–5 | date = July 1995 | pmid = 7493477 | doi = 10.1111/j.1600-0536.1995.tb00462.x | s2cid = 41533643 }}{{cite journal | vauthors = Del Pozo MD, Blasco A, Lobera T | title = Tetrazepam allergy | journal = Allergy | volume = 54 | issue = 11 | pages = 1226–7 | date = November 1999 | pmid = 10604563 | doi = 10.1034/j.1398-9995.1999.00362.x | s2cid = 46139378 }} Drug rash and drug-induced eosinophilia with systemic symptoms is a known complication of tetrazepam exposure.{{cite journal | vauthors = Dinić-Uzurov V, Lalosević V, Milosević I, Urosević I, Lalosević D, Popović S | title = [Current differential diagnosis of hypereosinophilic syndrome] | journal = Medicinski Pregled | volume = 60 | issue = 11–12 | pages = 581–6 | date = November 2007 | pmid = 18666600 | doi = 10.2298/MPNS0712581D }}{{cite journal | vauthors = Bachmeyer C, Assier H, Roujeau JC, Blum L | title = Probable drug rash with eosinophilia and systemic symptoms syndrome related to tetrazepam | journal = Journal of the European Academy of Dermatology and Venereology | volume = 22 | issue = 7 | pages = 887–9 | date = July 2008 | pmid = 18031497 | doi = 10.1111/j.1468-3083.2007.02490.x | s2cid = 12775035 }} These hypersensitive allergic reactions can be of the delayed type.{{cite journal | vauthors = Blanco R, Díez-Gómez ML, Gala G, Quirce S | title = Delayed hypersensitivity to tetrazepam | journal = Allergy | volume = 52 | issue = 11 | pages = 1146–7 | date = November 1997 | pmid = 9404574 | doi = 10.1111/j.1398-9995.1997.tb00194.x | s2cid = 5381089 }}{{cite journal | vauthors = Ortega NR, Barranco P, López Serrano C, Romualdo L, Mora C | title = Delayed cell-mediated hypersensitivity to tetrazepam | journal = Contact Dermatitis | volume = 34 | issue = 2 | pages = 139 | date = February 1996 | pmid = 8681544 | doi = 10.1111/j.1600-0536.1996.tb02147.x | s2cid = 46147524 }}{{cite journal | vauthors = Kämpgen E, Bürger T, Bröcker EB, Klein CE | title = Cross-reactive type IV hypersensitivity reactions to benzodiazepines revealed by patch testing | journal = Contact Dermatitis | volume = 33 | issue = 5 | pages = 356–7 | date = November 1995 | pmid = 8565501 | doi = 10.1111/j.1600-0536.1995.tb02060.x | s2cid = 23398517 }}
Toxic epidermal necrolysis has occurred from the use of tetrazepam{{cite journal | vauthors = Delesalle F, Carpentier O, Guatier S, Delaporte E | title = Toxic epidermal necrolysis caused by tetrazepam | journal = International Journal of Dermatology | volume = 45 | issue = 4 | pages = 480 | date = April 2006 | pmid = 16650186 | doi = 10.1111/j.1365-4632.2006.02654.x | s2cid = 221815580 }}{{cite journal | vauthors = Wolf R, Orion E, Davidovici B | title = Toxic epidermal necrolysis caused by tetrazepam | journal = International Journal of Dermatology | volume = 45 | issue = 10 | pages = 1260–1 | date = October 2006 | pmid = 17040464 | doi = 10.1111/j.1365-4632.2006.03061.x | s2cid = 221815889 }} including at least one reported death.{{cite journal | vauthors = Lagnaoui R, Ramanampamonjy R, Julliac B, Haramburu F, Ticolat R | title = [Fatal toxic epidermal necrolysis associated with tetrazepam | journal = Therapie | volume = 56 | issue = 2 | pages = 187–8 | date = March 2001 | pmid = 11471372 }} Stevens–Johnson syndrome and erythema multiforme has been reported from use of tetrazepam. Cross-reactivity with other benzodiazepines does not typically occur in such patients.{{cite journal | vauthors = Pirker C, Misic A, Brinkmeier T, Frosch PJ | title = Tetrazepam drug sensitivity -- usefulness of the patch test | journal = Contact Dermatitis | volume = 47 | issue = 3 | pages = 135–8 | date = September 2002 | pmid = 12492544 | doi = 10.1034/j.1600-0536.2002.470302.x | s2cid = 5932398 }}{{cite journal | vauthors = Sánchez I, García-Abujeta JL, Fernández L, Rodríguez F, Quiñones D, Duque S, López R, Jerez J | title = Stevens-Johnson syndrome from tetrazepam | journal = Allergologia et Immunopathologia | volume = 26 | issue = 2 | pages = 55–7 | date = 2 March 1998 | pmid = 9645262 | url = http://www.elsevier.es/revistas/ctl_servlet?_f=7064&ip=90.216.52.234&articuloid=13011386&revistaid=105 | access-date = 14 September 2009 | archive-date = 25 November 2020 | archive-url = https://web.archive.org/web/20201125091827/https://www.elsevier.es/revistas/ctl_servlet?_f=7064&ip=90.216.52.234&articuloid=13011386&revistaid=105 | url-status = dead }}{{cite journal | vauthors = Rodríguez Vázquez M, Ortiz de Frutos J, del Río Reyes R, Iglesias Díez L | title = [Erythema multiforme by tetrazepam] | journal = Medicina Clinica | volume = 115 | issue = 9 | pages = 359 | date = September 2000 | pmid = 11093904 | doi = 10.1016/s0025-7753(00)71559-4 }} Exanthema{{cite journal | vauthors = Ghislain PD, Roussel S, Bouffioux B, Delescluse J | title = [Tetrazepam (Myolastan)-induced exanthema: positive patch tests in 2 cases] | journal = Annales de Dermatologie et de Vénéréologie | volume = 127 | issue = 12 | pages = 1094–6 | date = December 2000 | pmid = 11173688 }} and eczema may occur.{{cite journal | vauthors = Breuer K, Worm M, Skudlik C, Schröder C, John SM | title = Occupational airborne contact allergy to tetrazepam in a geriatric nurse | journal = Journal of the German Society of Dermatology | volume = 7 | issue = 10 | pages = 896–8 | date = October 2009 | pmid = 19453384 | doi = 10.1111/j.1610-0387.2009.07096.x | s2cid = 29339528 }} The lack of cross-reactivity with other benzodiazepines is believed to be due to the molecular structure of tetrazepam.{{cite journal | vauthors = Barbaud A, Girault PY, Schmutz JL, Weber-Muller F, Trechot P | title = No cross-reactions between tetrazepam and other benzodiazepines: a possible chemical explanation | journal = Contact Dermatitis | volume = 61 | issue = 1 | pages = 53–6 | date = July 2009 | pmid = 19659970 | doi = 10.1111/j.1600-0536.2009.01558.x | s2cid = 205813960 }}{{cite journal | vauthors = Cabrerizo Ballesteros S, Méndez Alcalde JD, Sánchez Alonso A | title = Erythema multiforme to tetrazepam | journal = Journal of Investigational Allergology & Clinical Immunology | volume = 17 | issue = 3 | pages = 205–6 | year = 2007 | pmid = 17583114 | url = http://www.jiaci.org/issues/vol17issue03/14to17.pdf }} Photodermatitis{{cite journal | vauthors = Quiñones D, Sanchez I, Alonso S, Garcia-Abujeta JL, Fernandez L, Rodriguez F, Martin-Gil D, Jerez J | title = Photodermatitis from tetrazepam | journal = Contact Dermatitis | volume = 39 | issue = 2 | pages = 84 | date = August 1998 | pmid = 9746190 | doi = 10.1111/j.1600-0536.1998.tb05840.x | s2cid = 40771488 }} and phototoxicity have also been reported.{{cite journal | vauthors = Schwedler S, Mempel M, Schmidt T, Abeck D, Ring J | title = Phototoxicity to tetrazepam - A new adverse reaction | journal = Dermatology | volume = 197 | issue = 2 | pages = 193–4 | year = 1998 | pmid = 9840980 }} Occupational contact allergy can also develop from regularly handling tetrazepam.{{cite journal | vauthors = Choquet-Kastylevsky G, Testud F, Chalmet P, Lecuyer-Kudela S, Descotes J | title = Occupational contact allergy to tetrazepam | journal = Contact Dermatitis | volume = 44 | issue = 6 | pages = 372 | date = June 2001 | pmid = 11417526 | doi = 10.1034/j.1600-0536.2001.440609-7.x }}{{cite journal | vauthors = Lepp U, Zabel P, Greinert U | title = Occupational airborne contact allergy to tetrazepam | journal = Contact Dermatitis | volume = 49 | issue = 5 | pages = 260–1 | date = November 2003 | pmid = 14996051 | doi = 10.1111/j.0105-1873.2003.0225c.x | s2cid = 11238687 }} Airborne contact dermatitis can also occur as an allergy which can develop from occupational exposure.{{cite journal | vauthors = Ferran M, Giménez-Arnau A, Luque S, Berenguer N, Iglesias M, Pujol RM | title = Occupational airborne contact dermatitis from sporadic exposure to tetrazepam during machine maintenance | journal = Contact Dermatitis | volume = 52 | issue = 3 | pages = 173–4 | date = March 2005 | pmid = 15811045 | doi = 10.1111/j.0105-1873.2005.0548o.x | s2cid = 30499424 }}
Patch testing has been used successfully to demonstrate tetrazepam allergy.{{cite journal | vauthors = Barbaud A, Gonçalo M, Bruynzeel D, Bircher A | s2cid = 10780935 | title = Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions | journal = Contact Dermatitis | volume = 45 | issue = 6 | pages = 321–8 | date = December 2001 | pmid = 11846746 | doi = 10.1034/j.1600-0536.2001.450601.x | doi-access = free }}{{cite journal | vauthors = Barbaud A, Trechot P, Reichert-Penetrat S, Granel F, Schmutz JL | title = The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam | journal = Contact Dermatitis | volume = 44 | issue = 4 | pages = 259–60 | date = April 2001 | pmid = 11336014 | doi = 10.1034/j.1600-0536.2001.440409-15.x | s2cid = 40786622 }} Oral testing can also be used. Skin prick tests are not always accurate and may produce false negatives.{{cite journal | vauthors = Sánchez-Morillas L, Laguna-Martínez JJ, Reaño-Martos M, Rojo-Andrés E, Ubeda PG | title = Systemic dermatitis due to tetrazepam | journal = Journal of Investigational Allergology & Clinical Immunology | volume = 18 | issue = 5 | pages = 404–6 | year = 2008 | pmid = 18973107 | url = http://www.jiaci.org/issues/vol18issue5/14.pdf }}
Drowsiness is a common side effect of tetrazepam.{{cite journal | vauthors = Rode G, Maupas E, Luaute J, Courtois-Jacquin S, Boisson D | title = [Medical treatment of spasticity] | journal = Neuro-Chirurgie | volume = 49 | issue = 2–3 Pt 2 | pages = 247–55 | date = May 2003 | pmid = 12746699 }} A reduction in muscle force can occur.{{cite journal | vauthors = Lobisch M, Schaffler K, Wauschkuhn H, Nickel B | title = [Clinical pilot study of the myogenic effects of flupirtine in comparison to tetrazepam and placebo] | journal = Arzneimittel-Forschung | volume = 46 | issue = 3 | pages = 293–8 | date = March 1996 | pmid = 8901152 }} Myasthenia gravis, a condition characterised by severe muscle weakness is another potential adverse effect from tetrazepam.{{cite journal | vauthors = Vargas Ortega I, Canora Lebrato J, Díez Ruiz A, Rico Irles J | title = [Myasthenia gravis after tetrazepam treatment] | journal = Anales de Medicina Interna | volume = 17 | issue = 12 | pages = 669 | date = December 2000 | pmid = 11213590 | doi = 10.4321/s0212-71992000001200016 | doi-access = free }} Cardiovascular and respiratory adverse effects can occur with tetrazepam similar to other benzodiazepines.
=Tolerance, dependence and withdrawal=
{{See also|Benzodiazepine withdrawal syndrome}}
Prolonged use, as with all benzodiazepines, should be avoided, as tolerance occurs and there is a risk of benzodiazepine dependence and a benzodiazepine withdrawal syndrome after stopping or reducing dosage.
Overdose
{{See also|Benzodiazepine overdose}}
Tetrazepam, like other benzodiazepines is a drug which is very frequently present in cases of overdose. These overdoses are often mixed overdoses, i.e. a mixture of other benzodiazepines or other drug classes with tetrazepam.{{cite journal | vauthors = Zevzikovas A, Bertulyte A, Dirse V, Ivanauskas L | title = [Determination of benzodiazepine derivatives mixture by high performance liquid chromatography] | journal = Medicina | volume = 39 | pages = 30–6 | year = 2003 | issue = Suppl 2 | pmid = 14617855 }}{{cite journal | vauthors = Zevzikovas A, Kiliuviene G, Ivanauskas L, Dirse V | title = [Analysis of benzodiazepine derivative mixture by gas-liquid chromatography] | language = lithuanian | journal = Medicina | volume = 38 | issue = 3 | pages = 316–20 | year = 2002 | pmid = 12474705 | url = http://medicina.kmu.lt/0203/0203-12l.pdf | access-date = 2009-09-14 | archive-date = 2011-07-22 | archive-url = https://web.archive.org/web/20110722151944/http://medicina.kmu.lt/0203/0203-12l.pdf | url-status = dead }}
Contraindications and special caution
Benzodiazepines require special precaution if used in the elderly, during pregnancy, in children, alcohol or drug-dependent individuals and individuals with comorbid psychiatric disorders.{{cite journal | vauthors = Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, Vennat B, Llorca PM, Eschalier A | title = Benzodiazepine dependence: focus on withdrawal syndrome | journal = Annales Pharmaceutiques Françaises | volume = 67 | issue = 6 | pages = 408–13 | date = November 2009 | pmid = 19900604 | doi = 10.1016/j.pharma.2009.07.001 }}
Pharmacology
Tetrazepam is an unusual benzodiazepine in its molecular structure as it has cyclohexenyl group which has substituted the typical 5-phenyl moiety seen in other benzodiazepines.{{cite journal | vauthors = Pavlic M, Libiseller K, Grubwieser P, Schubert H, Rabl W | title = Medicolegal aspects of tetrazepam metabolism | journal = International Journal of Legal Medicine | volume = 121 | issue = 3 | pages = 169–74 | date = May 2007 | pmid = 17021899 | doi = 10.1007/s00414-006-0118-6 | s2cid = 32405914 }}
Tetrazepam, is rapidly absorbed after oral administration, within 45 mins and reaches peak plasma levels in less than 2 hours. It is classed as an intermediate acting benzodiazepine with an elimination half-life of approximately 15 hours. It is primarily metabolised to the inactive metabolites 3-hydroxy-tetrazepam and nortetrazepam.{{cite journal | vauthors = Baumgärtner MG, Cautreels W, Langenbahn H | title = Biotransformation and pharmacokinetics of tetrazepam in man | journal = Arzneimittel-Forschung | volume = 34 | issue = 6 | pages = 724–9 | year = 1984 | pmid = 6148954 }} The pharmacological effects of tetrazepam are significantly less potent when compared against diazepam, in animal studies.{{cite journal | vauthors = Keane PE, Simiand J, Morre M, Biziere K | title = Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 245 | issue = 2 | pages = 692–8 | date = May 1988 | pmid = 2896794 }} Tetrazepam is a benzodiazepine site agonist and binds unselectively to type 1 and type 2 benzodiazepine site types as well as to peripheral benzodiazepine receptors.{{cite journal | vauthors = Keane PE, Bachy A, Morre M, Biziere K | title = Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 245 | issue = 2 | pages = 699–705 | date = May 1988 | pmid = 2896795 }} The muscle relaxant properties of tetrazepam are most likely due to a reduction of calcium influx.{{cite journal | vauthors = Pérez-Guerrero C, Suárez J, Herrera MD, Marhuenda E | title = Spasmolytic effects of tetrazepam on rat duodenum and guinea-pig ileum | journal = Pharmacological Research | volume = 35 | issue = 5 | pages = 493–7 | date = May 1997 | pmid = 9299217 | doi = 10.1006/phrs.1997.0173 }} Small amounts of diazepam as well as the active metabolites of diazepam are produced from metabolism of tetrazepam.{{cite journal | vauthors = Baumann A, Lohmann W, Schubert B, Oberacher H, Karst U | title = Metabolic studies of tetrazepam based on electrochemical simulation in comparison to in vivo and in vitro methods | journal = Journal of Chromatography A | volume = 1216 | issue = 15 | pages = 3192–8 | date = April 2009 | pmid = 19233363 | doi = 10.1016/j.chroma.2009.02.001 }}{{cite journal | vauthors = Schubert B, Pavlic M, Libiseller K, Oberacher H | title = Unraveling the metabolic transformation of tetrazepam to diazepam with mass spectrometric methods | journal = Analytical and Bioanalytical Chemistry | volume = 392 | issue = 7–8 | pages = 1299–308 | date = December 2008 | pmid = 18949465 | doi = 10.1007/s00216-008-2447-4 | s2cid = 10967477 }} The metabolism of tetrazepam has led to false accusations of prisoners prescribed tetrazepam of taking illicit diazepam; this can lead to increased prison sentences for prisoners.
Abuse
{{See also|Drug-related crime|Benzodiazepine misuse}}
Tetrazepam as with other benzodiazepines is sometimes abused. It is sometimes abused to incapacitate a victim in order to carry out a drug-facilitated crime.{{cite journal | vauthors = Concheiro M, Villain M, Bouchet S, Ludes B, López-Rivadulla M, Kintz P | title = Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimes | journal = Therapeutic Drug Monitoring | volume = 27 | issue = 5 | pages = 565–70 | date = October 2005 | pmid = 16175127 | doi = 10.1097/01.ftd.0000164610.14808.45 | s2cid = 45605607 }} or abused in order to achieve a state of intoxication.{{cite journal | vauthors = Kintz P, Villain M, Concheiro M, Cirimele V | title = Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS | journal = Forensic Science International | volume = 150 | issue = 2–3 | pages = 213–20 | date = June 2005 | pmid = 15944062 | doi = 10.1016/j.forsciint.2004.12.040 }}
Tetrazepam's abuse for to carry out drug facilitated crimes may be less however, than other benzodiazepines due to its reduced hypnotic properties.{{cite journal | vauthors = Laloup M, Fernandez M, Wood M, Maes V, De Boeck G, Vanbeckevoort Y, Samyn N | title = Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan and Valium | journal = Analytical and Bioanalytical Chemistry | volume = 388 | issue = 7 | pages = 1545–56 | date = August 2007 | pmid = 17468852 | doi = 10.1007/s00216-007-1297-9 | s2cid = 19256926 }}
See also
References
{{Reflist|32em}}
{{Benzodiazepines}}
{{Muscle relaxants}}
{{GABAAR PAMs}}